Stevens Capital Management LP Ligand Pharmaceuticals Inc Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 03, 2019
SELL
$105.93 - $142.47 $1.04 Million - $1.4 Million
-9,843 Closed
0 $0
Q4 2018

Feb 06, 2019
BUY
$128.36 - $272.13 $1.26 Million - $2.68 Million
9,843 New
9,843 $1.34 Million
Q3 2018

Nov 13, 2018
SELL
$211.18 - $274.49 $659,937 - $857,781
-3,125 Closed
0 $0
Q2 2018

Aug 09, 2018
BUY
$150.77 - $207.98 $471,156 - $649,937
3,125 New
3,125 $647,000

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email